Navigation Links
Omthera Announces Waiver of Lock-Up Restriction
Date:7/11/2013

PRINCETON, N.J., July 11, 2013 /PRNewswire/ -- Omthera Pharmaceuticals, Inc. (the "Company") announced today that BofA Merrill Lynch and Barclays, the lead book-running managers in the Company's recent public sale of 8,000,000 shares of common stock, is waiving a lock-up restriction with respect to all outstanding shares of the Company's common stock held by the shareholders, officers and directors of the Company in connection with certain dispositions related to the Company's announced definitive merger agreement with an affiliate of AstraZeneca PLC.  The waiver will take effect on July 15, 2013, and the shares may be disposed of on or after such date in accordance with the terms of the waiver.

This press release is not an offer for sale of the securities in the United States or in any other jurisdiction where such offer is prohibited, and such securities may not be offered or sold in the United States absent registration or an exemption from registration under the United States Securities Act of 1933, as amended.

About Omthera Pharmaceuticals, Inc.

Omthera Pharmaceuticals, Inc. is an emerging specialty pharmaceutical company focused on the development and commercialization of new therapies for dyslipidemia and the treatment of cardiovascular disease. Epanova™, currently the Company's sole product candidate, is a late-stage, novel, omega-3 free fatty acid composition that meaningfully reduces triglycerides, improves other key lipid parameters and is expected to increase patient convenience with 2-gram once-a-day dosing with or without meals. Epanova™ is a coated soft gelatin capsule containing a complex mixture of polyunsaturated free fatty acids derived from fish oils, including multiple long-chain omega-3 and omega-6 fatty acids, with EPA, DHA, and docosapentaenoic acid being the most abundant forms of omega-3 fatty acids. The Company has co
'/>"/>

SOURCE Omthera Pharmaceuticals, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Omthera Pharmaceuticals Announces Record Date and Meeting Date for Special Meeting of Stockholders
2. Omthera Pharmaceuticals, Inc. Stockholders Seeking More Money, Information in Buyout Should Contact Deans & Lyons Law Firm
3. Omthera Pharmaceuticals Announces First Quarter 2013 Financial Results
4. Covington Advises Omthera Pharmaceuticals on Merger with AstraZeneca
5. Omthera Pharmaceuticals, Inc. Announces Closing of Initial Public Offering
6. Omthera Pharmaceuticals, Inc. Announces Pricing of Initial Public Offering
7. Omthera Pharmaceuticals Presents Data From Analysis Of EVOLVE Trial Showing That Epanova Lowers ApoC-III, A Key Predictor of Cardiovascular Risk
8. Omthera Pharmaceuticals Announces Invitation to Attend Presentation of the Complete Data Sets from its Phase 3 EVOLVE and ESPRIT Clinical Studies
9. Omthera Pharmaceuticals Announces Positive Top-Line Results from Phase 3 EVOLVE Study
10. CryoLife Announces Release Date and Teleconference Call Details for 2013 Second Quarter Financial Results
11. UM Ventures Announces Collaboration Between UM School Of Medicines Dr. Frank Robb and Fina Biosolutions
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/2/2015)... 2015 Research and Markets( http://www.researchandmarkets.com/research/nlfg34/cancer ) ... Technology, Imaging and by Application - Forecast to 2020" report ... expected to reach $13.1 Billion in 2020 from an estimated $7.1 ... The market is dominated by North America , ... , and Rest of the World (RoW). The cancer diagnostics market ...
(Date:7/2/2015)... 2015  The Green Exchange, Inc., the developer,s of ... compliant mobile app that connects cannabis growers directly to ... announced today that their service provides the fastest delivery ... more than half a dozen other delivery apps that ... is unique in that it connects growers directly ...
(Date:7/2/2015)... , July 2, 2015 Pharma Major ... in ZAO "Biocom" in Russia subject ... the Russian pharmaceutical market which recorded RUB 765 billion in ... markets in the world in 2014 (IMS Health). For over ... expected to continue with this trend, projecting Russia ...
Breaking Medicine Technology:Global Cancer Diagnostics Market Report 2015 - Technology, Imaging and by Applications Forecasts to 2020 for the $13 Billion Industry 2New Cannabis Delivery App Gets Product to Patient in Under 7 Minutes 2Lupin Acquires Biocom in Russia 2Lupin Acquires Biocom in Russia 3
... Waltham, Mass., June 7, 2007 – Dynogen Pharmaceuticals,Inc. ... 1b trial of DDP733 for gastroesophageal,reflux disease (GERD). ... DDP733 as a treatment for nocturnal GERD,(NGERD). ... statistical,significance over placebo on the primary endpoint of ...
... 2007 - AVANIR,Pharmaceuticals (NASDAQ:AVNR) today announced ... efficacy, safety and improvements in,patient-centered outcomes ... pain treated with the investigational drug,Zenvia(TM) ... sigma-1 agonist. The data were accepted ...
Cached Medicine Technology:Dynogen's DDP733 Reduces Reflux in Phase 1b GERD Study 2Dynogen's DDP733 Reduces Reflux in Phase 1b GERD Study 3AVANIR Pharmaceuticals Presents Zenvia Phase III Data in Diabetic,Peripheral Neuropathic Pain at International Congress on,Neuropathic Pain 2AVANIR Pharmaceuticals Presents Zenvia Phase III Data in Diabetic,Peripheral Neuropathic Pain at International Congress on,Neuropathic Pain 3AVANIR Pharmaceuticals Presents Zenvia Phase III Data in Diabetic,Peripheral Neuropathic Pain at International Congress on,Neuropathic Pain 4AVANIR Pharmaceuticals Presents Zenvia Phase III Data in Diabetic,Peripheral Neuropathic Pain at International Congress on,Neuropathic Pain 5AVANIR Pharmaceuticals Presents Zenvia Phase III Data in Diabetic,Peripheral Neuropathic Pain at International Congress on,Neuropathic Pain 6AVANIR Pharmaceuticals Presents Zenvia Phase III Data in Diabetic,Peripheral Neuropathic Pain at International Congress on,Neuropathic Pain 7
(Date:7/3/2015)... ... July 03, 2015 , ... B. ... has been retained to lead a national president recruitment for Regional ... the healthcare industry, B. E. Smith has recently placed more than 1,000 healthcare ...
(Date:7/3/2015)... ... July 03, 2015 , ... The Erie County ... 2015 at 1:00pm. The Association welcomed speaker C. Daniel McGillicuddy Esq. of William ... practical points of investigating these types of cases. , Each year, New York ...
(Date:7/3/2015)... , ... July 03, 2015 , ... Talcum powder attorneys ... replace their existing Talcum Powder Cancer Lawsuit Center website. Just as the previous version ... lawsuit news , offering timely lawsuit updates and ovarian cancer warning information. The site ...
(Date:7/3/2015)... , ... July 03, 2015 , ... First Choice ... States, named Mariah N. Manzanares, MD as the new Medical Director of its Frisco ... medical director of our Frisco facility,” said Dr. James M. Muzzarelli, Executive Medical Director ...
(Date:7/3/2015)... ... 03, 2015 , ... Yisrayl Hawkins, Pastor and Overseer at The House of ... will reveal biblical truth and expose popular lies regarding proper relationships according to the ... Sex”, immediately goes into the core of the subject by explaining why certain types ...
Breaking Medicine News(10 mins):Health News:Regional Care, Inc. Retains B. E. Smith to Recruit New President 2Health News:Regional Care, Inc. Retains B. E. Smith to Recruit New President 3Health News:Attorney from William Mattar Leads Discussion on Bicycle Accidents 2Health News:Talcum Powder Lawsuit News: Cancer Attorneys Launch Updated Mobile Site 2Health News:Talcum Powder Lawsuit News: Cancer Attorneys Launch Updated Mobile Site 3Health News:First Choice Emergency Room Announces Dr. Mariah N. Manzanares as Medical Director of Frisco, TX Facility 2Health News:First Choice Emergency Room Announces Dr. Mariah N. Manzanares as Medical Director of Frisco, TX Facility 3Health News:Yisrayl Hawkins Explains What the Bible Really Says about Sex in New Publication This Week 2
... Oncology (ASTRO) has named its 2010 class of Fellows. ... at a ceremony during the 52nd Annual Meeting being ... San Diego Convention Center in San Diego. "ASTRO Fellows ... of the radiation oncology community and receiving this distinction ...
... Reporter , WEDNESDAY, July 7 (HealthDay News) -- Patients with ... via e-mail got better care and better health outcomes, new ... the e-mail exchanges included such measures as blood sugar and ... Health Affairs . The American Recovery and Reinvestment ...
... of marijuana in California could cut the price of the ... according to a new study by the nonprofit RAND Corporation ... in the state. While the state Board of Equalization ... billion in revenue, the RAND study cautions that any potential ...
... Ill., July 7, 2010 The Natural Orifice ... joint effort of the American Society for Gastrointestinal ... and Endoscopic Surgeons (SAGES), announces the completion of ... using Natural Orifice Translumenal Endoscopic Surgery (NOTES) in ...
... multicenter clinical trial to compare natural orifice translumenal endoscopic ... California, San Diego School of Medicine have performed the ... evaluate whether or not NOTES is safe and as ... is the first in the world to compare oral ...
... By Steven Reinberg HealthDay Reporter , WEDNESDAY, July ... signs of colorectal cancer is less accurate when done in ... researchers report. Although the particular brand of test ... not used in the United States, the findings are of ...
Cached Medicine News:Health News:ASTRO announces 2010 Fellows class 2Health News:Doctor-Patient E-Mails Are a Healthy Addition, Research Shows 2Health News:Doctor-Patient E-Mails Are a Healthy Addition, Research Shows 3Health News:Legalizing marijuana in California would lower the price of the drug and increase use, study finds 2Health News:Legalizing marijuana in California would lower the price of the drug and increase use, study finds 3Health News:Legalizing marijuana in California would lower the price of the drug and increase use, study finds 4Health News:NOSCAR announces first NOTES transoral and transvaginal gallbladder removals performed as part of US multicenter human trial 2Health News:First US surgery to compare NOTES vs. laparoscopy 2Health News:Could Hot Weather Affect Results of a Colorectal Cancer Test? 2Health News:Could Hot Weather Affect Results of a Colorectal Cancer Test? 3Health News:Could Hot Weather Affect Results of a Colorectal Cancer Test? 4
Inquire...
VACUETTE paediatric tubes have decreased sample volumes and are ideal for small childrens' veins and geriatric patients....
VACUETTE paediatric tubes have decreased sample volumes and are ideal for small childrens' veins and geriatric patients....
Inquire...
Medicine Products: